Document

Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl Into Schedule I

The Drug Enforcement Administration proposes placing beta- hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin- 4-yl]-N-phenylpropionamide) also known as N-[1-...

The Drug Enforcement Administration proposes placing beta- hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin- 4-yl]-N-phenylpropionamide) also known as N-[1-[2-hydroxy-2-(2- thienyl)ethyl]4-piperidinyl]N-phenyl-propanamide including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle beta-hydroxythiofentanyl.

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

83 FR 21826

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl Into Schedule I,” thefederalregister.org (May 10, 2018), https://thefederalregister.org/documents/2018-10008/schedules-of-controlled-substances-placement-of-beta-hydroxythiofentanyl-into-schedule-i.